WA
PACB icon

Wealth Architects’s Pacific Biosciences PACB Stock Holding History

Wealth Architects’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$81.9K Hold
48,725
– – 0.01% 247
2026
Q1 		$64.3K Hold
48,725
– – 0.01% 244
2025
Q4 		$91.1K Hold
48,725
– – 0.01% 240
2025
Q3 		$62.4K Hold
48,725
– – 0.01% 235
2025
Q2 		$60.4K Hold
48,725
– – 0.01% 226
2025
Q1 		$57.5K Hold
48,725
– – 0.01% 229
2024
Q4 		$89.2K Sell
48,725
-102
-0.2% -$199 0.01% 215
2024
Q3 		$83K Buy
48,827
+102
+0.2% +$168 0.01% 214
2024
Q2 		$66.8K Sell
48,725
-3,718
-7% -$7.51K 0.01% 210
2024
Q1 		$197K Buy
+52,443
New +$307K 0.03% 202

Other funds holding PACB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Wealth Architects's PACB Position: Q2 2026 in Review

Wealth Architects held its Pacific Biosciences (PACB) position steady in Q2 2026 at 48,725 shares worth $81.9K. The position accounts for 0.01% of the portfolio, ranked #247.

Wealth Architects first reported a position in PACB in Q1 2024 and has held it in 10 quarters since. The position peaked at $197K in Q1 2024. 223 funds tracked by Wall St. Rank hold PACB as of Q2 2026.

  • Wealth Architects held 48,725 shares of Pacific Biosciences worth $81.9K as of Q2 2026.
  • Wealth Architects left its Pacific Biosciences share count unchanged in Q2 2026.
  • Pacific Biosciences made up 0.01% of Wealth Architects's portfolio in Q2 2026, its #247 holding.
  • Wealth Architects first reported a position in Pacific Biosciences in Q1 2024 and has held it in 10 quarters since.
  • Wealth Architects's Pacific Biosciences position peaked at $197K in Q1 2024.
  • 223 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.

Based on Wealth Architects's 13F filing for Q2 2026, filed 23 Jul 2026.